AxoSim
AxoSim, Inc. is a premier provider of neurological drug discovery platforms. The company's proprietary BrainSim™ and NerveSim™ platforms provide accurate, predictive models of the peripheral and central nervous systems, rapidly delivering clinically-actionable human data early in the drug development process. AxoSim's platforms have applications for drug efficacy, disease modeling, and toxicology.
Last updated on
About AxoSim
Founded
2014Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$11MCategory
Sector
Commercial Physical and Biological ResearchIndustry Group
Research, Development, and Testing ServicesIndustry
Engineering, Accounting, Research, Management, and Related ServicesLocation
City
New OrleansState
LouisianaCountry
United StatesAxoSim
Find your buyer within AxoSim